FDA Brief

Company record

Chengdu Innovation Pharmaceutical Co., Ltd.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Chengdu Innovation Pharmaceutical Co., Ltd..

Warning letters

  1. Chengdu Innovation Pharmaceutical Co., Ltd.

    FDA warned Chengdu Innovation Pharmaceutical over CGMP (manufacturing quality rules) failures in API (drug ingredient) manufacturing, including no identity testing of incoming materials.

    High risk